Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal magnesium sulfate dose-ranging trial for prevention of shivering during spinal anesthesia
IRCT20260225068945N1Phase 2Completed
- Sponsor
- Khyber Medical University
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of magnesium sulfate in postanesthetic shivering (PAS) (4 arms), sponsored by Khyber Medical University. Primary endpoints: Incidence of shivering, Severity of shivering and 10 more. Started Jun 2026; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20260225068945N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260225068945N1.